Home
PTC Therapeutics PTCT spent $160K on lobbying in Q4 2022 · Medicare, Taxation and 2 more issues
Trade details
- Type
- Lobbying report
- Amount
- $160,000
- Quarter
- Q4 2022
- Client
- PTC Therapeutics
- Reported
- 23/01/20
Down 15.8% from last quarter
What else happened in PTC Therapeutics around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30PTC Therapeutics's other lobbying reports
- PTC Therapeutics
LobbyingPTC Therapeutics
LobbyingPTC Therapeutics
PTCT
$50K
$50K
Reported 07/20
for Q2
- PTC Therapeutics
LobbyingPTC Therapeutics
LobbyingPTC Therapeutics
PTCT
$170K
$170K
Reported 07/20
for Q2
- PTC Therapeutics
LobbyingPTC Therapeutics
LobbyingPTC Therapeutics
PTCT
$50K
$50K
Reported 07/05
for Q2
- PTC Therapeutics
LobbyingPTC Therapeutics
LobbyingPTC Therapeutics
PTCT
$50K
$50K
Reported 04/20
for Q1
- PTC Therapeutics
LobbyingPTC Therapeutics
LobbyingPTC Therapeutics
PTCT
$390K
$390K
Reported 04/20
for Q1